A Study of HDM2020 in Patients With Advanced Solid Tumors
Clinical trial NCT07098052 · RECRUITING
Trial details
- NCT number
- NCT07098052
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2026-09-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.